AbSci Corporation (ABSI) Actualités

Form 8-K - Current report

Absci to Participate in Upcoming Investor Conferences

VANCOUVER, Wash. and NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Released results from non-human primate studies for ABS-101, demonstrating 2-3x extended half-life as compared...

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

VANCOUVER, Wash. and NEW YORK, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Today, Absci Corporation (Nasdaq: ABSI), a...

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

VANCOUVER, Wash. and NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a...

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, Wash. and NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 144 - Report of proposed sale of securities

Absci to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit

VANCOUVER, Wash. and NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a...